| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $304,001 | 5 | 100 |
Sells | $0 | 0 | 0 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 2 | $210,587 | 0 | $0 | $210,587 |
| ASADORIAN RAFFI | Chief Financial Officer | 1 | $36,554 | 0 | $0 | $36,554 |
| Aslam Shakil | Chief Medical Officer | 1 | $28,431 | 0 | $0 | $28,431 |
| Dasu Badri N | Chief Engineering Officer | 1 | $28,431 | 0 | $0 | $28,431 |
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimental candidate is Niyad, a lyophilized (freeze-dried) formulation of nafamostat. This anticoagulant is currently being assessed under an investigational device exemption for its application in extracorporeal circuits. The company's development pipeline also features LTX-608, a potential anti-inflammatory and antiviral agent being explored for the …
Over the last 12 months, insiders at Talphera, Inc. have bought $304,001 and sold $0 worth of Talphera, Inc. stock.
On average, over the past 5 years, insiders at Talphera, Inc. have bought $153,114 and sold $119 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Angotti Vincent J. (CHIEF EXECUTIVE OFFICER) — $210,587. ASADORIAN RAFFI (Chief Financial Officer) — $36,554. Aslam Shakil (Chief Medical Officer) — $28,431.
The last purchase of 213,310 shares for transaction amount of $125,000 was made by Angotti Vincent J. (CHIEF EXECUTIVE OFFICER) on 2026‑03‑13.
| 2026-03-13 | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 213,310 0.7646% | $0.59 | $125,000 | +34.29% | ||
| 2026-02-12 | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 105,364 0.5208% | $0.81 | $85,587 | +27.42% | ||
| 2026-02-12 | ASADORIAN RAFFI | Chief Financial Officer | 45,000 0.2224% | $0.81 | $36,554 | +27.42% | ||
| 2026-02-12 | Aslam Shakil | Chief Medical Officer | 35,000 0.173% | $0.81 | $28,431 | +27.42% | ||
| 2026-02-12 | Dasu Badri N | Chief Engineering Officer | 35,000 0.173% | $0.81 | $28,431 | +27.42% | ||
| 2025-04-02 | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 213,310 1.254% | $0.59 | $125,000 | +38.94% | ||
| 2024-12-05 | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 5,000 0.0274% | $0.64 | $3,200 | -17.04% | ||
| 2024-12-02 | Sale | ASADORIAN RAFFI | Chief Financial Officer | 155 0.0009% | $0.77 | $119 | -24.34% | |
| 2024-11-27 | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 5,000 0.0303% | $0.73 | $3,650 | -21.80% | ||
| 2024-08-30 | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 7,260 0.0631% | $1.05 | $7,598 | -44.60% | ||
| 2024-06-14 | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 1,304 0.0117% | $1.08 | $1,404 | -34.81% | ||
| 2024-06-14 | Aslam Shakil | Chief Medical Officer | 5,000 0.0445% | $1.07 | $5,357 | -34.81% | ||
| 2024-06-13 | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 4,570 0.0369% | $0.97 | $4,438 | -29.28% | ||
| 2024-06-13 | Aslam Shakil | Chief Medical Officer | 695 0.0057% | $0.98 | $681 | -29.28% | ||
| 2024-06-12 | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 4,126 0.0333% | $0.97 | $4,013 | -29.08% |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 800705 1.5426% | $832,733.20 | 9 | 0 | <0.0001% |
| ASADORIAN RAFFI | Chief Financial Officer | 91256 0.1758% | $94,906.24 | 1 | 1 | |
| Aslam Shakil | Chief Medical Officer | 83178 0.1602% | $86,505.12 | 3 | 0 | <0.0001% |
| Dasu Badri N | Chief Engineering Officer | 76230 0.1469% | $79,279.20 | 1 | 0 |
$2,101,005 | 2135 | -11.51% | $64.58M | |
$131,310,609 | 62 | 26.99% | $107.44M | |
$30,221,759 | 51 | 0.50% | $20.6M | |
$2,767,882 | 51 | 8.70% | $24.78M | |
$33,884,330 | 45 | 12.56% | $223.45M |
| Increased Positions | 21 | +60% | 4M | +22.4% |
| Decreased Positions | 12 | -34.29% | 892,913 | -5.02% |
| New Positions | 10 | New | 2M | New |
| Sold Out Positions | 6 | Sold Out | 45,338 | Sold Out |
| Total Postitions | 44 | +25.71% | 21M | +17.38% |
| Aigh Capital Management Llc | $5,167.00 | 9.48% | 4.45M | +4M | New | 2025-09-30 |
| Rosalind Advisors, Inc. | $5,087.00 | 9.33% | 4.39M | +2M | +118.86% | 2025-09-30 |
| Rock Springs Capital Management Lp | $4,163.00 | 7.64% | 3.59M | +3M | +1,034.17% | 2025-09-30 |
| Nantahala Capital Management, Llc | $4,051.00 | 7.43% | 3.49M | +2M | +75.28% | 2025-09-30 |
| Bleichroeder Lp | $1,022.00 | 1.88% | 881,166 | +454,545 | +106.55% | 2025-09-30 |
| Vanguard Group Inc | $332.00 | 0.61% | 286,229 | +204,871 | +251.81% | 2025-09-30 |
| Geode Capital Management, Llc | $192.00 | 0.35% | 165,693 | +299 | +0.18% | 2025-09-30 |
| Dauntless Investment Group, Llc | $116.00 | 0.21% | 100,000 | +100,000 | New | 2025-09-30 |
| Values First Advisors, Inc. | $114.00 | 0.21% | 97,882 | -1,329 | -1.34% | 2025-09-30 |
| Blackrock, Inc. | $106.00 | 0.2% | 91,548 | 0 | 0% | 2025-09-30 |